Vuélvete ilimitado con Magzter GOLD

Vuélvete ilimitado con Magzter GOLD

Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo

$149.99
 
$74.99/Año
The Perfect Holiday Gift Gift Now

Experts for public labs to detect contamination

Ingredients South Asia

|

December 1-15, 2025

AMIDST the increasing cases of children death linked to cough syrup contamination with the recent one in Madhya Pradesh's Chhindwara on October 31, experts have advocated that public drug testing labs should adopt advanced testing methods to detect contamination in cough syrups.

- SHARDUL NAUTIYAL, MUMBAI

Experts for public labs to detect contamination

Ghaziabad based Indian Pharmacopoeia Commission (IPC) under the Union Health Ministry has also rolled out a series of hands on training workshops for public drug testing labs pan India, according to official sources.

These workshops will prominently feature training in gas chromatography (GC) for testing contamination with high levels of ethylene glycol (EG) and diethylene glycol (DEG) in medicines.

A five-month-old girl died in Madhya Pradesh's Chhindwara district allegedly after consuming Ayurvedic cough syrup. The incident comes amid the deaths of 25 children over the past two months in Chhindwara and neighbouring districts due to renal failure linked to 'Coldrif', an allopathic cough syrup found contaminated with high levels of toxic industrial solvents like ethylene glycol (EG) and diethylene glycol (DEG) in medicines.

In the Coldrif syrup case, the police have so far arrested six persons, including proprietor of the manufacturing company Sresan Pharmaceuticals, and a local paediatrician.

Close on the heels of such growing incidents, the IPC has developed a free toolkit by compiling pharmacopoeial and regulatory resources to address contamination with high levels of EG and DEG associated with liquid oral medicines, particularly in allergy, cold and cough syrups.

This document serves as a comprehensive reference, compiling key general chapters and monographs from the IP, available reference standards, along with relevant international guidances. The resources are intended to support excipients and raw material suppliers, drug manufacturers, testing laboratories, and regulatory agencies.

MÁS HISTORIAS DE Ingredients South Asia

Ingredients South Asia

Ingredients South Asia

With 50.40% in 2024, captive APIs led the market

PHARMACEUTICAL ingredients are mainly divided into two parts i.e. active and inactive pharmaceutical ingredients.

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

Ingredients South Asia

As mfg evolves, quality control must adapt

IN the pharmaceutical industry, the quality of raw materials especially active pharmaceutical ingredients (APIs) and excipients is what makes medicines safe, effective and trustworthy.

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

Ingredients South Asia

The unspoken designers of effective drug treatment

Medicine has been related to the active pharmaceutical ingredient (API), the chemical compound that produces therapeutic effect. However, the path between the discovery in a laboratory and a pill in your hand cannot be fully made without excipients.

time to read

5 mins

December 1-15, 2025

Ingredients South Asia

Ingredients South Asia

Adv fermentation can convert agri waste into cosmetic actives

The natural cosmetics industry is growing at an unprecedented rate. The global market is expected to grow from $52.4 billion in 2025 to $95.7 billion by 2035, which is a strong compound annual growth rate of 5.7%.

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

India's cold storage leap: Driving food security

INDIA'S agriculture sector, with a GDP of $262 billion, showcases remarkable resilience, being minimally dependent on imports.

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

Transforming India's ingredient mfg landscape

COME December 19-21, 2025, the pharmaceutical world will descend on Bengaluru, not just for another congress, but for a high-stakes convergence of technology, education, and industry - the 74th Indian Pharmaceutical Congress (IPC).

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

in-cos attracts celebs at star-studded edition

IN-cosmetics Asia delivered its most influential edition to date. This year's event attracted a star-studded mix of high-profile industry leaders, Csuite executives, celebrity guests, Asian A-listers, beauty entrepreneurs and heads of some of the world's best-known cosmetics houses.

time to read

3 mins

December 1-15, 2025

Ingredients South Asia

Ingredients South Asia

CMOs optimise supply chain & reduce costs

PHARMACEUTICAL contract manufacturing is when pharmaceutical companies outsource drug production to specialised third-party manufacturers.

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

Ingredients South Asia

Modular and compact designs are gaining traction

INDIA'S pharmaceutical sector is often referred to as the “pharmacy of the world.” Behind this reputation lies not only drug formulation expertise but also the robust ecosystem of pharma processing machinery manufacturers.

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

DGFT resolves concern related to redemption of AAS

IN a significant relief for pharmaceutical exporters, the Directorate General of Foreign Trade (DGFT) has issued a clarification resolving a long-standing concern related to the redemption of Advance Authorisations (AAS) impacted by the erstwhile Rule 96(10) of the CGST Rules-2017.

time to read

2 mins

December 1-15, 2025

Listen

Translate

Share

-
+

Change font size

Holiday offer front
Holiday offer back